...
【24h】

Virus safety of human blood, plasma, and derived products.

机译:人体血液,血浆和衍生产品的病毒安全性。

获取原文
获取原文并翻译 | 示例

摘要

The reconstitution of blood and its components is hampered by factors of compatibility, availability, and the risk of transmission of infectious diseases. Protozoal agents such as plasmodium malariae and trypanosoma cruzi are only regionally relevant. Bacterial transmissions are easy to prevent and treat. Antibody, antigen, and nucleic acid screening have been implemented to prevent transmission of blood-borne viruses. Transfusion-relevant viruses include hepatitis B and C virus (HBV and HCV), human immunodeficiency virus (HIV), human T leukemia virus (HTLV-I), and in certain circumstances, parvovirus B19, hepatitis A virus (HAV), and cytomegalovirus (CMV).Of great concern is the possible transmission of prion protein causing transmissible spongiform encephalopathy. Of future interest will be whether other viruses such as Nipah and Hendra virus are blood-borne and whether viruses such as TT, SEN, and GBV-C are involved in diseases or their progression, while not causing hepatitis.
机译:血液及其成分的重构受到相容性,可利用性和传染病传播风险的因素的阻碍。疟原虫和克氏锥虫等原生动物制剂仅在地区相关。细菌传播很容易预防和治疗。已经进行了抗体,抗原和核酸筛选,以防止血液传播的病毒传播。与输血有关的病毒包括乙型和丙型肝炎病毒(HBV和HCV),人免疫缺陷病毒(HIV),人T白血病病毒(HTLV-1),以及在某些情况下的细小病毒B19,甲型肝炎病毒(HAV)和巨细胞病毒(CMV)。引起人们极大关注的是病毒蛋白的传播可能导致传染性海绵状脑病。未来将引起关注的是其他病毒(例如Nipah和Hendra病毒)是否是血源性病毒,以及TT,SEN和GBV-C等病毒是否与疾病或疾病进程有关,而不会引起肝炎。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号